GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $227,000 | -30.4% | 9,499 | -57.4% | 0.00% | – |
| Q4 2020 | $326,000 | -39.4% | 22,322 | -41.1% | 0.00% | -100.0% |
| Q3 2020 | $538,000 | +44.2% | 37,874 | +49.4% | 0.00% | 0.0% |
| Q2 2020 | $373,000 | +501.6% | 25,345 | +69.9% | 0.00% | – |
| Q1 2020 | $62,000 | +47.6% | 14,918 | +116.8% | 0.00% | – |
| Q3 2019 | $42,000 | +16.7% | 6,880 | -7.2% | 0.00% | – |
| Q4 2018 | $36,000 | -33.3% | 7,413 | 0.0% | 0.00% | – |
| Q3 2018 | $54,000 | +31.7% | 7,413 | +15.1% | 0.00% | – |
| Q2 2018 | $41,000 | +17.1% | 6,439 | 0.0% | 0.00% | – |
| Q1 2018 | $35,000 | +29.6% | 6,439 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | -56.5% | 6,439 | 0.0% | 0.00% | – |
| Q3 2017 | $62,000 | -18.4% | 6,439 | 0.0% | 0.00% | – |
| Q2 2017 | $76,000 | -6.2% | 6,439 | +1.7% | 0.00% | – |
| Q1 2017 | $81,000 | +5.2% | 6,329 | 0.0% | 0.00% | – |
| Q4 2016 | $77,000 | +8.5% | 6,329 | +5.9% | 0.00% | – |
| Q3 2016 | $71,000 | +44.9% | 5,977 | +7.2% | 0.00% | – |
| Q2 2016 | $49,000 | +75.0% | 5,578 | +4.1% | 0.00% | – |
| Q1 2016 | $28,000 | -26.3% | 5,359 | +8.4% | 0.00% | – |
| Q4 2015 | $38,000 | +2.7% | 4,944 | +5.9% | 0.00% | – |
| Q3 2015 | $37,000 | -5.1% | 4,670 | +8.3% | 0.00% | – |
| Q2 2015 | $39,000 | – | 4,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|